aspirin has been researched along with Abortion, Spontaneous in 114 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Abortion, Spontaneous: Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These findings suggest that a low-dose aspirin protocol is associated with increased hCG-detected pregnancy in women who adhere to treatment for at least 5 days per week." | 9.51 | Use of Machine Learning to Estimate the Per-Protocol Effect of Low-Dose Aspirin on Pregnancy Outcomes: A Secondary Analysis of a Randomized Clinical Trial. ( Bodnar, LM; Brooks, MM; Kennedy, EH; Naimi, AI; Zhong, Y, 2022) |
| "A previous large randomized trial indicated that preconception-initiated low-dose aspirin (LDA) therapy did not have a positive effect on pregnancy outcomes." | 9.41 | The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth : Per Protocol Analysis of a Randomized Trial. ( Mumford, SL; Naimi, AI; Perkins, NJ; Platt, RW; Schisterman, EF; Silver, RM; Sjaarda, LA, 2021) |
| "Prospective cohort study as a secondary analysis of the Effects of Aspirin in Gestation and Reproduction randomized controlled trial of preconception-initiated low-dose aspirin among women with one or two prior pregnancy losses." | 9.34 | Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial. ( Freeman, JR; Grewal, J; Mumford, SL; Perkins, NJ; Russo, LM; Schisterman, EF; Schliep, KC; Silver, RM; Sjaarda, LA; Whitcomb, BW, 2020) |
| "To evaluate the effect of adjuvant low-dose aspirin therapy on clinical pregnancy rate and uterine perfusion in women undergoing frozen-thawed embryo transfer (FET) cycles." | 9.30 | Does low-dose aspirin improve pregnancy rate in women undergoing frozen-thawed embryo transfer cycle? A pilot double-blind, randomized placebo-controlled trial. ( Ahmadi, F; Bagheri Lankarani, N; Bahmanabadi, A; Jahangiri, N; Madani, T, 2019) |
| "Low-dose aspirin is most effective in increasing pregnancy and live birth among women with no or few components of metabolic syndrome." | 9.30 | Metabolic Syndrome and the Effectiveness of Low-dose Aspirin on Reproductive Outcomes. ( Hill, M; Kim, K; Mendola, P; Mumford, SL; Naimi, AI; Nobles, CJ; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L, 2019) |
| " Considering the clear risk of complications during pregnancy -- especially the occurrence of spontaneous abortion in the first trimester -- and the risk of intrauterine fetal death, we believe all patients should at least be treated with aspirin unless there is a contraindication." | 8.81 | Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature. ( Vanstraelen, D; Vantroyen, B, 2002) |
| "The objective of this study was to assess pregnancy outcome in women with a history of refractory antiphospholipid antibody-associated pregnancy loss(es) who were treated with early low-dose prednisolone in addition to aspirin and heparin." | 7.77 | First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. ( Bramham, K; Hunt, BJ; Khamashta, M; Nelson-Piercy, C; Thomas, M, 2011) |
| "Treatment with prednisone and aspirin appears to be efficacious, safe, and economic in the prevention of pregnancy loss and fetal growth retardation in patients with aCL." | 7.68 | Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. ( Angel, J; Espinoza, LR; Hubble, CL; Jara, LJ; Martínez-Osuna, P; O'Brien, W; Saway, S; Seleznick, MJ; Silveira, LH, 1992) |
| "Hydroxychloroquine (HCQ) is an immunomodulatory agent that has been shown in laboratory studies to decrease thrombosis risk, support placentation, and minimize the destructive effects of antiphospholipid antibodies." | 7.01 | Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review. ( Bacal, V; Bedaiwy, MA; Hooper, A, 2023) |
| "Inflammation is linked to causes of infertility." | 6.84 | Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial. ( Galai, N; Mitchell, E; Mumford, SL; Perkins, NJ; Radin, RG; Schisterman, EF; Silver, RM; Sjaarda, LA; Stanford, JB; Wactawski-Wende, J; Wilcox, B, 2017) |
| "These findings suggest that a low-dose aspirin protocol is associated with increased hCG-detected pregnancy in women who adhere to treatment for at least 5 days per week." | 5.51 | Use of Machine Learning to Estimate the Per-Protocol Effect of Low-Dose Aspirin on Pregnancy Outcomes: A Secondary Analysis of a Randomized Clinical Trial. ( Bodnar, LM; Brooks, MM; Kennedy, EH; Naimi, AI; Zhong, Y, 2022) |
| " The evidence demonstrates that the treatments to consider are first-trimester progesterone administration, levothyroxine in women with subclinical hypothyroidism, and the combination of aspirin and heparin in women with antiphospholipid antibodies." | 5.41 | Interventions to prevent miscarriage. ( Coomarasamy, A; Devall, A; Dhillon-Smith, RK; Fox, E; Kaur, R; Melo, P; Woodhead, N, 2023) |
| "A previous large randomized trial indicated that preconception-initiated low-dose aspirin (LDA) therapy did not have a positive effect on pregnancy outcomes." | 5.41 | The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth : Per Protocol Analysis of a Randomized Trial. ( Mumford, SL; Naimi, AI; Perkins, NJ; Platt, RW; Schisterman, EF; Silver, RM; Sjaarda, LA, 2021) |
| "Prospective cohort study as a secondary analysis of the Effects of Aspirin in Gestation and Reproduction randomized controlled trial of preconception-initiated low-dose aspirin among women with one or two prior pregnancy losses." | 5.34 | Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial. ( Freeman, JR; Grewal, J; Mumford, SL; Perkins, NJ; Russo, LM; Schisterman, EF; Schliep, KC; Silver, RM; Sjaarda, LA; Whitcomb, BW, 2020) |
| "Low-dose aspirin is most effective in increasing pregnancy and live birth among women with no or few components of metabolic syndrome." | 5.30 | Metabolic Syndrome and the Effectiveness of Low-dose Aspirin on Reproductive Outcomes. ( Hill, M; Kim, K; Mendola, P; Mumford, SL; Naimi, AI; Nobles, CJ; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L, 2019) |
| "To evaluate the effect of adjuvant low-dose aspirin therapy on clinical pregnancy rate and uterine perfusion in women undergoing frozen-thawed embryo transfer (FET) cycles." | 5.30 | Does low-dose aspirin improve pregnancy rate in women undergoing frozen-thawed embryo transfer cycle? A pilot double-blind, randomized placebo-controlled trial. ( Ahmadi, F; Bagheri Lankarani, N; Bahmanabadi, A; Jahangiri, N; Madani, T, 2019) |
| "After treatment the pregnancy wastage rate was 55% and 25% in the 2 groups respectively." | 5.28 | Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment. ( Cameron, K; Gatenby, PA; Shearman, RP, 1989) |
| " We evaluated preconception blood pressure and fecundability, pregnancy loss, and live birth in the EAGeR trial (Effects of Aspirin on Gestational and Reproduction; 2007-2011), a randomized clinical trial of aspirin and reproductive outcomes among 1228 women attempting pregnancy with a history of pregnancy loss." | 5.27 | Preconception Blood Pressure Levels and Reproductive Outcomes in a Prospective Cohort of Women Attempting Pregnancy. ( Kim, K; Mendola, P; Mumford, SL; Naimi, AI; Nobles, CJ; Park, H; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L; Wilcox, B; Yeung, EH, 2018) |
| "A randomized clinical trial, Effects of Aspirin in Gestation and Reproduction, enrolled women with 1 or 2 prior pregnancy losses at 4 US clinical centers from June 15, 2007, to July 15, 2011." | 5.22 | Association of Nausea and Vomiting During Pregnancy With Pregnancy Loss: A Secondary Analysis of a Randomized Clinical Trial. ( Galai, N; Grantz, KL; Hinkle, SN; Mitchell, EM; Mumford, SL; Perkins, NJ; Radin, RG; Schisterman, EF; Silver, RM; Sjaarda, LA, 2016) |
| "Randomized controlled trials (RCTs) and retrospective cohort studies that used aspirin as an adjuvant treatment for endometrial preparation and reported subsequent pregnancy outcomes were included." | 5.12 | Aspirin for Endometrial Preparation in Patients Undergoing IVF: A Systematic Review and Meta-analysis. ( Albaini, O; Antaki, R; Jamal, W; Mourad, A, 2021) |
| "A high success rate is achieved when low-dose aspirin is used for antiphospholipid syndrome in pregnancy." | 5.10 | Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. ( Farquharson, RG; Greaves, M; Quenby, S, 2002) |
| "The results of this study do not show a substantial efficacy of aspirin inwomen undergoing IVF/ICSI and do not support the use of low-dose aspirin to improve the success of IVF/ICSI in terms of pregnancy outcomes." | 4.88 | Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature. ( Ageno, W; Dentali, F; Grandone, E; Margaglione, M; Middeldorp, S; Rancan, E; Rezoagli, E; Squizzato, A, 2012) |
| " The combination of heparin and low-dose aspirin is effective in significantly increasing the chances of a successful pregnancy in woman with recurrent pregnancy failure associated with antiphospholipid antibodies." | 4.81 | Treatment of the antiphospholipid syndrome. ( Roubey, RA, 2002) |
| " Considering the clear risk of complications during pregnancy -- especially the occurrence of spontaneous abortion in the first trimester -- and the risk of intrauterine fetal death, we believe all patients should at least be treated with aspirin unless there is a contraindication." | 4.81 | Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature. ( Vanstraelen, D; Vantroyen, B, 2002) |
| " It seems effective for the prevention of recurrent pregnancy losses when conventional strategies using subcutaneous heparin and low-dose aspirin have failed." | 4.80 | [Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome]. ( Lê Thi Huong, D; Piette, JC; Wechsler, B, 2000) |
| "The gold standard for treatment of the antiphospholipid antibody syndrome (APS) after thrombosis remains high-intensity warfarin, and, in pregnancy, heparin and aspirin." | 4.80 | Treatment of the antiphospholipid antibody syndrome: progress in the last five years? ( Petri, M, 2000) |
| "The Effects of Aspirin in Gestation and Reproduction trial (2007-2011) enrolled 1228 women attempting pregnancy and followed them for up to 6 menstrual cycles and throughout pregnancy if they became pregnant." | 4.31 | The Relationship of Preconception and Early Pregnancy Isoprostanes with Fecundability and Pregnancy Loss. ( Kim, K; Mendola, P; Mumford, SL; Nobles, CJ; Perkins, NJ; Schisterman, EF; Silver, RM, 2023) |
| "Women with persistent aPL on aspirin had pregnancy outcomes that were similar to controls." | 3.79 | Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes. ( Gray, G; Nelson-Piercy, C; Pasupathy, D; Soh, MC, 2013) |
| "The objective of this study was to assess pregnancy outcome in women with a history of refractory antiphospholipid antibody-associated pregnancy loss(es) who were treated with early low-dose prednisolone in addition to aspirin and heparin." | 3.77 | First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. ( Bramham, K; Hunt, BJ; Khamashta, M; Nelson-Piercy, C; Thomas, M, 2011) |
| "Our results suggest that aspirin may increase clinical pregnancy rates and that more data are needed to resolve the issue." | 3.74 | Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization. ( Collins, TC; Ruopp, MD; Schisterman, EF; Whitcomb, BW, 2008) |
| "Use of aspirin during pregnancy is not associated with an increased risk of miscarriage." | 3.73 | Aspirin use and miscarriage risk. ( Keim, SA; Klebanoff, MA, 2006) |
| "The present report shows that in treated APS pregnancies: i) aspirin treatment started preconceptionally is an independent and significant prognostic factor associated with favorable fetal outcome; and ii) abnormal velocity waveforms in the umbilical artery predict adverse outcome of pregnancy." | 3.71 | Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis. ( Azulay, M; Balasch, J; Carmona, F; Cervera, R; Creus, M; Fábregues, F; Font, J; Puerto, B, 2001) |
| "Treatment with prednisone and aspirin appears to be efficacious, safe, and economic in the prevention of pregnancy loss and fetal growth retardation in patients with aCL." | 3.68 | Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. ( Angel, J; Espinoza, LR; Hubble, CL; Jara, LJ; Martínez-Osuna, P; O'Brien, W; Saway, S; Seleznick, MJ; Silveira, LH, 1992) |
| " During their next pregnancy, the patients were treated with 40 to 50 mg of prednisone per day and 81 mg of aspirin per day." | 3.67 | Obstetric complications associated with the lupus anticoagulant. ( Branch, DW; Hershgold, E; Kochenour, NK; Scott, JR, 1985) |
| "Hydroxychloroquine (HCQ) is an immunomodulatory agent that has been shown in laboratory studies to decrease thrombosis risk, support placentation, and minimize the destructive effects of antiphospholipid antibodies." | 3.01 | Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review. ( Bacal, V; Bedaiwy, MA; Hooper, A, 2023) |
| "Inflammation is linked to causes of infertility." | 2.84 | Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial. ( Galai, N; Mitchell, E; Mumford, SL; Perkins, NJ; Radin, RG; Schisterman, EF; Silver, RM; Sjaarda, LA; Stanford, JB; Wactawski-Wende, J; Wilcox, B, 2017) |
| "Recurrent miscarriage and later pregnancy complications are in some cases associated with placental thrombosis and infarction." | 2.69 | Recurrent miscarriage--an aspirin a day? ( Backos, M; Baxter, N; Chilcott, I; Rai, R; Regan, L, 2000) |
| "Miscarriage, premature delivery, and preeclampsia, as well as heart problems in the baby are the major complications that can occur." | 2.53 | Pregnancy in women with systemic lupus erythematosus (SLE). ( Moroni, G; Ponticelli, C, 2016) |
| " Careful attention must be paid to the dosing and potential teratogenicity of medications." | 2.52 | Pregnancy and Lupus Nephritis. ( Garovic, VD; Kattah, AG, 2015) |
| "a previous history of miscarriage, foetal loss, placental insufficiency or thrombosis." | 2.47 | Lupus and pregnancy: integrating clues from the bench and bedside. ( Khamashta, MA; Ruiz-Irastorza, G, 2011) |
| "The antiphospholipid syndrome is an antibody mediated hypercoagulable state characterized by recurrent venous and arterial thromboembolic events." | 2.44 | [The antiphospholipid syndrome, an update]. ( Alonso Santor, JE; Inglada Galiana, L; Pérez Paredes, G, 2007) |
| "Many authors relate this factor with preeclampsia, intrauterine fetal growth retardation, spontaneous abortion, unexplained cases of still birth, placental abruption, and thromboembolic complications during and after parturition." | 2.42 | [Factor V Leiden mutation and pregnancy complications]. ( Abraitis, V; Mockeviciene, A; Mongirdiene, A, 2003) |
| "Recently, the thrombophilias have been revealed as risk factors for severe preeclampsia, abruptio placentae, fetal growth retardation, abortion and still birth as well." | 2.42 | [Anticoagulation and antiaggregation during pregnancy]. ( Biasiutti, FD; Strebel, JK, 2003) |
| "The risk of preeclampsia and placental insufficiency was substantial and occurred in 50% of patients." | 2.42 | Antiphospholipid syndrome in obstetrics. ( Heilmann, L; Pollow, K; von Tempelhoff, GF, 2003) |
| "Placental infarction due to thrombosis seems to be the most consistent event." | 2.40 | Fertility, pregnancy and the management of myeloproliferative disorders. ( Bergmann, L; Griesshammer, M; Pearson, T, 1998) |
| "Aspirin (ASS) was the most frequently used drug in 47 of 93 recorded cases (51%)." | 2.39 | Essential thrombocythemia and pregnancy. ( Griesshammer, M; Heimpel, H; Pearson, TC, 1996) |
| "Positive b-hCG, miscarriage, and live birth rates were similar between groups as Group A vs." | 1.91 | Low Molecular Weight Heparin-Aspirin-Prednisolone Combination Does Not Increase the Live Birth Rate in Recurrent Implantation Failure: A Retrospective Cohort Study. ( Aslan, K; Avci, B; Cakir, C; Cinar, C; Kasapoglu, I; Uncu, G, 2023) |
| "Antiphospholipid syndrome is associated with recurrent pregnancy loss." | 1.62 | "Part of the Ritual": Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome. ( Bates, SM; Gonsalves, C; Karovitch, A; Rodger, MA; Skeith, L; Taylor, TS, 2021) |
| "Nine pregnancies ended in miscarriages (9/34; 26." | 1.62 | Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety. ( Becker, T; Griesshammer, M; Heidel, FH; Hochhaus, A; Kolatzki, V; Sadjadian, P; Schrickel, L; Wille, K, 2021) |
| "Recurrent spontaneous abortion is one of the common complications in women of childbearing age during pregnancy." | 1.48 | [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome]. ( Li, XY; Liu, XY; Zhao, JX, 2018) |
| "(2) Influence of treatment on the pregnancy outcomes and complications: 24 APS patients were given the treatment of aspirin or aspirin combined with low molecular weight heparin, and 30 patients received no treatment." | 1.40 | [Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study]. ( Deng, XL; Liu, XY; Zheng, XJ, 2014) |
| "To describe the diagnosis and treatment of antiphospholipid syndrome as it relates to spontaneous abortion." | 1.37 | A practical approach to the prevention of miscarriage: part 5--antiphospholipid syndrome as a cause of spontaneous abortion. ( Check, JH, 2011) |
| "Furthermore, the occurrence of a miscarriage in ET might be a marker for a similar event during subsequent pregnancies." | 1.35 | Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies. ( Gangat, N; Schwager, S; Tefferi, A; Wolanskyj, AP, 2009) |
| "We estimated the proportion of miscarriage to be almost doubled, whereas there was no increased risk of congenital abnormalities or prematurity in women exposed to a drug overdose compared with the background population." | 1.31 | Pregnancy outcome after suicide attempt by drug use: a Danish population-based study. ( Flint, C; Larsen, H; Nielsen, GL; Olsen, J; Sørensen, HT, 2002) |
| "Patients with antiphospholipid syndrome are at high risk of pregnancy loss as well as maternal morbidity, especially thrombo-embolic disease." | 1.30 | Obstetric outcome in antiphospholipid syndrome. ( Farquharson, RG; Granger, KA, 1997) |
| "After treatment the pregnancy wastage rate was 55% and 25% in the 2 groups respectively." | 1.28 | Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment. ( Cameron, K; Gatenby, PA; Shearman, RP, 1989) |
| "Aspirin has been proven to inhibit PGs liberation." | 1.25 | [Prostaglandins]. ( , 1973) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (7.02) | 18.7374 |
| 1990's | 21 (18.42) | 18.2507 |
| 2000's | 35 (30.70) | 29.6817 |
| 2010's | 31 (27.19) | 24.3611 |
| 2020's | 19 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, Y | 1 |
| Brooks, MM | 1 |
| Kennedy, EH | 1 |
| Bodnar, LM | 1 |
| Naimi, AI | 4 |
| Moar, L | 1 |
| Simela, C | 1 |
| Nanda, S | 1 |
| Marnerides, A | 1 |
| Al-Adnani, M | 1 |
| Nelson-Piercy, C | 4 |
| Nicolaides, KH | 1 |
| Shangaris, P | 1 |
| Xu, X | 4 |
| Wang, J | 4 |
| Zhu, D | 4 |
| Yin, J | 4 |
| Liu, J | 3 |
| Wu, X | 3 |
| Yang, W | 3 |
| Hu, Q | 3 |
| Ren, Y | 3 |
| Zhang, Z | 4 |
| Zhou, P | 3 |
| Wei, Z | 3 |
| Zou, H | 4 |
| Cao, Y | 4 |
| Aslan, K | 1 |
| Kasapoglu, I | 1 |
| Cinar, C | 1 |
| Cakir, C | 1 |
| Avci, B | 1 |
| Uncu, G | 1 |
| Nobles, CJ | 3 |
| Mendola, P | 3 |
| Mumford, SL | 10 |
| Silver, RM | 10 |
| Kim, K | 3 |
| Perkins, NJ | 9 |
| Schisterman, EF | 11 |
| Hooper, A | 1 |
| Bacal, V | 1 |
| Bedaiwy, MA | 1 |
| Dhillon-Smith, RK | 1 |
| Melo, P | 1 |
| Kaur, R | 1 |
| Fox, E | 1 |
| Devall, A | 1 |
| Woodhead, N | 1 |
| Coomarasamy, A | 1 |
| Orieke, D | 1 |
| Ohaeri, OC | 1 |
| Ijeh, II | 1 |
| Ijioma, SN | 1 |
| Liu, X | 1 |
| Qiu, Y | 1 |
| Yu, ED | 1 |
| Xiang, S | 1 |
| Meng, R | 1 |
| Niu, KF | 1 |
| Zhu, H | 1 |
| Rodriguez-Pintó, I | 1 |
| Espinosa, G | 1 |
| Cervera, R | 2 |
| Xiang, H | 1 |
| Russo, LM | 1 |
| Whitcomb, BW | 2 |
| Freeman, JR | 1 |
| Sjaarda, LA | 7 |
| Schliep, KC | 4 |
| Grewal, J | 1 |
| Schrickel, L | 1 |
| Heidel, FH | 1 |
| Sadjadian, P | 1 |
| Becker, T | 1 |
| Kolatzki, V | 1 |
| Hochhaus, A | 1 |
| Griesshammer, M | 4 |
| Wille, K | 1 |
| Gangat, N | 2 |
| Tefferi, A | 3 |
| Skeith, L | 1 |
| Rodger, MA | 1 |
| Bates, SM | 1 |
| Gonsalves, C | 1 |
| Karovitch, A | 1 |
| Taylor, TS | 1 |
| Platt, RW | 1 |
| Mourad, A | 1 |
| Antaki, R | 1 |
| Jamal, W | 1 |
| Albaini, O | 1 |
| Radin, RG | 4 |
| Mitchell, E | 1 |
| Wilcox, B | 2 |
| Galai, N | 5 |
| Wactawski-Wende, J | 3 |
| Stanford, JB | 2 |
| Abdulghani, S | 1 |
| Moretti, F | 1 |
| Gruslin, A | 1 |
| Grynspan, D | 1 |
| Yeung, EH | 1 |
| Park, H | 1 |
| Sjaarda, L | 2 |
| Madani, T | 1 |
| Ahmadi, F | 1 |
| Jahangiri, N | 1 |
| Bahmanabadi, A | 1 |
| Bagheri Lankarani, N | 1 |
| Li, XY | 1 |
| Zhao, JX | 1 |
| Liu, XY | 2 |
| Egan, AM | 1 |
| Brassill, MJ | 1 |
| Brosnan, E | 1 |
| Carmody, L | 1 |
| Clarke, H | 1 |
| Coogan Kelly, C | 1 |
| Culliney, L | 1 |
| Durkan, M | 1 |
| Fenlon, M | 1 |
| Ferry, P | 1 |
| Hanlon, G | 1 |
| Higgins, T | 1 |
| Hoashi, S | 1 |
| Khamis, A | 1 |
| Kinsley, B | 1 |
| Kinsley, T | 1 |
| Kirwan, B | 1 |
| Liew, A | 1 |
| McGurk, C | 1 |
| McHugh, C | 1 |
| Murphy, MS | 1 |
| Murphy, P | 1 |
| O'Halloran, D | 1 |
| O'Mahony, L | 1 |
| O'Sullivan, E | 1 |
| Nolan, M | 1 |
| Peter, M | 1 |
| Roberts, G | 1 |
| Smyth, A | 1 |
| Todd, M | 1 |
| Tuthill, A | 1 |
| Wan Mahmood, WA | 1 |
| Yousif, O | 1 |
| P Dunne, F | 1 |
| Hill, M | 1 |
| Soh, MC | 1 |
| Pasupathy, D | 1 |
| Gray, G | 1 |
| Zhu, Q | 1 |
| Wu, L | 1 |
| Xu, B | 1 |
| Hu, MH | 1 |
| Tong, XH | 1 |
| Ji, JJ | 1 |
| Liu, YS | 1 |
| Zheng, XJ | 1 |
| Deng, XL | 1 |
| Bao, S | 1 |
| Liao, H | 1 |
| Shuai, W | 1 |
| Wang, L | 1 |
| Hu, J | 1 |
| Mone, F | 1 |
| McAuliffe, FM | 1 |
| Lesher, LL | 2 |
| Faraggi, D | 2 |
| Townsend, JM | 2 |
| Lynch, AM | 2 |
| Simhan, HN | 1 |
| Zarek, SM | 3 |
| Kattah, AG | 1 |
| Garovic, VD | 1 |
| Mitchell, EM | 2 |
| Plowden, TC | 1 |
| DeCherney, AH | 1 |
| Patil, R | 1 |
| Ghosh, K | 2 |
| Mukherjee, S | 1 |
| Shetty, S | 2 |
| Moroni, G | 1 |
| Ponticelli, C | 1 |
| Hinkle, SN | 1 |
| Grantz, KL | 1 |
| Kang, X | 1 |
| Wang, T | 1 |
| He, L | 1 |
| Xu, H | 1 |
| Liu, Z | 1 |
| Zhao, A | 1 |
| Latino, JO | 1 |
| Udry, S | 1 |
| Aranda, FM | 1 |
| Perés Wingeyer, SDA | 1 |
| Fernández Romero, DS | 1 |
| de Larrañaga, GF | 1 |
| Roumi, JE | 1 |
| Moukhadder, HM | 1 |
| Graziadei, G | 1 |
| Pennisi, M | 1 |
| Cappellini, MD | 1 |
| Taher, AT | 1 |
| Lazzarin, N | 1 |
| Vaquero, E | 1 |
| Exacoustos, C | 1 |
| Bertonotti, E | 1 |
| Romanini, ME | 1 |
| Arduini, D | 1 |
| Wolanskyj, AP | 1 |
| Schwager, S | 1 |
| Hughes, GR | 1 |
| Ruiz-Irastorza, G | 2 |
| Khamashta, MA | 2 |
| Check, JH | 1 |
| Bramham, K | 1 |
| Thomas, M | 1 |
| Khamashta, M | 2 |
| Hunt, BJ | 2 |
| Ruffatti, A | 1 |
| Tonello, M | 1 |
| Visentin, MS | 1 |
| Bontadi, A | 1 |
| Hoxha, A | 1 |
| De Carolis, S | 1 |
| Botta, A | 1 |
| Salvi, S | 1 |
| Nuzzo, M | 1 |
| Rovere-Querini, P | 1 |
| Canti, V | 1 |
| Mosca, M | 1 |
| Mitic, G | 1 |
| Bertero, MT | 1 |
| Pengo, V | 1 |
| Boffa, MC | 1 |
| Tincani, A | 1 |
| Kabisch, M | 1 |
| Ruckes, C | 1 |
| Seibert-Grafe, M | 1 |
| Blettner, M | 1 |
| Sibai, BM | 2 |
| Blackwell, SC | 1 |
| Tormene, D | 1 |
| Grandone, E | 2 |
| De Stefano, V | 1 |
| Tosetto, A | 1 |
| Palareti, G | 1 |
| Margaglione, M | 2 |
| Castaman, G | 1 |
| Rossi, E | 1 |
| Ciminello, A | 1 |
| Valdrè, L | 1 |
| Legnani, C | 1 |
| Tiscia, GL | 1 |
| Bafunno, V | 1 |
| Carraro, S | 1 |
| Rodeghiero, F | 1 |
| Simioni, P | 1 |
| Dentali, F | 1 |
| Ageno, W | 1 |
| Rezoagli, E | 1 |
| Rancan, E | 1 |
| Squizzato, A | 1 |
| Middeldorp, S | 1 |
| Farquharson, RG | 2 |
| Quenby, S | 1 |
| Greaves, M | 1 |
| Hickstein, H | 1 |
| Barz, D | 1 |
| Külz, T | 1 |
| Korten, G | 1 |
| Müller, H | 1 |
| Schmidt, R | 1 |
| Biasiutti, FD | 1 |
| Strebel, JK | 1 |
| Heilmann, L | 1 |
| von Tempelhoff, GF | 1 |
| Pollow, K | 1 |
| Mertens, D | 1 |
| Stone, S | 1 |
| Langford, K | 1 |
| Seed, PT | 1 |
| Poston, L | 1 |
| Li, DK | 1 |
| Liu, L | 1 |
| Odouli, R | 1 |
| Abraitis, V | 1 |
| Mongirdiene, A | 1 |
| Mockeviciene, A | 1 |
| Gromnica-Ihle, E | 1 |
| Niittyvuopio, R | 1 |
| Juvonen, E | 1 |
| Kaaja, R | 2 |
| Oksanen, K | 1 |
| Hallman, H | 1 |
| Timonen, T | 1 |
| Ruutu, T | 1 |
| Monastiri, K | 1 |
| Seket, B | 1 |
| Chouchane, S | 1 |
| Samama, MM | 1 |
| Mahjoub, T | 1 |
| Keim, SA | 1 |
| Klebanoff, MA | 1 |
| De Santis, M | 1 |
| Cavaliere, AF | 1 |
| Straface, G | 1 |
| Di Gianantonio, E | 1 |
| Caruso, A | 1 |
| Yamaguchi, K | 1 |
| Hisano, M | 1 |
| Sakata, M | 1 |
| Minatogawa, Y | 1 |
| Suzuki, T | 1 |
| Ozawa, N | 1 |
| Kitagawa, M | 1 |
| Murashima, A | 1 |
| Aguilera, C | 1 |
| Agustí, A | 1 |
| Srivastava, AR | 1 |
| Modi, P | 1 |
| Sahi, S | 1 |
| Niwariya, Y | 1 |
| Singh, H | 1 |
| Banerjee, A | 1 |
| Ruopp, MD | 1 |
| Collins, TC | 1 |
| Alonso Santor, JE | 1 |
| Inglada Galiana, L | 1 |
| Pérez Paredes, G | 1 |
| Vroom, F | 1 |
| van den Berg, PB | 1 |
| de Jong-van den Berg, LT | 1 |
| Zahner, J | 1 |
| Wehmeier, A | 1 |
| Schneider, W | 1 |
| Gordon, T | 1 |
| Thom, E | 1 |
| Caritis, SN | 1 |
| Klebanoff, M | 1 |
| McNellis, D | 1 |
| Paul, RH | 1 |
| Christiansen, OB | 1 |
| Lauritsen, JG | 1 |
| Clark, DA | 1 |
| Banwatt, D | 1 |
| Chaouat, G | 1 |
| Yagami, Y | 1 |
| Rogov, VA | 1 |
| Tareeva, IE | 1 |
| Sidorova, IS | 1 |
| Androsova, SO | 1 |
| Katamadze, KT | 1 |
| Nikiforova, OV | 1 |
| Julkunen, H | 1 |
| Ammälä, P | 1 |
| Palosuo, T | 1 |
| Kurki, P | 1 |
| Balasch, J | 2 |
| Font, J | 2 |
| Heimpel, H | 1 |
| Pearson, TC | 1 |
| Horbach, DA | 1 |
| Derksen, RH | 1 |
| de Groot, PG | 1 |
| Mazzucconi, MG | 1 |
| Dragoni, F | 1 |
| Chistolini, A | 1 |
| Peraino, M | 1 |
| Paesano, R | 1 |
| Di Prima, M | 1 |
| Di Francesco, F | 1 |
| Masala, C | 1 |
| Pachì, A | 1 |
| Reece, EA | 1 |
| Garofalo, J | 1 |
| Zheng, XZ | 1 |
| Assimakopoulos, E | 1 |
| Cowchock, S | 1 |
| Granger, KA | 1 |
| Geva, E | 1 |
| Amit, A | 1 |
| Lerner-Geva, L | 1 |
| Lessing, JB | 1 |
| Sullivan, MH | 1 |
| Clark, NA | 1 |
| de Swiet, M | 1 |
| Elder, MG | 1 |
| Hughes, G | 1 |
| Denis, E | 1 |
| Dufour, P | 1 |
| Vinatier, D | 1 |
| Valat, AS | 1 |
| Subtil, D | 1 |
| Puech, F | 1 |
| Hatron, PY | 1 |
| Bergmann, L | 1 |
| Pearson, T | 1 |
| Aoki, K | 2 |
| Piette, JC | 2 |
| Lê Thi Huong, D | 1 |
| Wechsler, B | 2 |
| Rai, R | 1 |
| Backos, M | 1 |
| Baxter, N | 1 |
| Chilcott, I | 1 |
| Regan, L | 1 |
| Bangerter, M | 1 |
| Güthner, C | 1 |
| Beneke, H | 1 |
| Hildebrand, A | 1 |
| Grünewald, M | 1 |
| Petri, M | 1 |
| Wright, CA | 1 |
| Ogasawara, MS | 1 |
| Iinuma, Y | 1 |
| Katano, K | 1 |
| Ozaki, Y | 1 |
| Suzumori, K | 1 |
| Carmona, F | 1 |
| Azulay, M | 1 |
| Creus, M | 1 |
| Fábregues, F | 1 |
| Puerto, B | 1 |
| Vantroyen, B | 1 |
| Vanstraelen, D | 1 |
| Roubey, RA | 1 |
| Flint, C | 1 |
| Larsen, H | 1 |
| Nielsen, GL | 1 |
| Olsen, J | 1 |
| Sørensen, HT | 1 |
| Kutteh, WH | 1 |
| Rote, NS | 1 |
| Williams, KI | 1 |
| Vane, JR | 1 |
| Bell, DP | 1 |
| Gibson, JG | 1 |
| McCarroll, AM | 1 |
| McClean, GA | 1 |
| Silveira, LH | 1 |
| Hubble, CL | 1 |
| Jara, LJ | 1 |
| Saway, S | 1 |
| Martínez-Osuna, P | 1 |
| Seleznick, MJ | 1 |
| Angel, J | 1 |
| O'Brien, W | 1 |
| Espinoza, LR | 1 |
| Blétry, O | 1 |
| Laraki, R | 1 |
| Cosserat, J | 1 |
| Gatenby, PA | 1 |
| Cameron, K | 1 |
| Shearman, RP | 1 |
| Branch, DW | 1 |
| Scott, JR | 1 |
| Kochenour, NK | 1 |
| Hershgold, E | 1 |
| Pickles, VR | 1 |
| Frohberg, H | 1 |
| Adebahr, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Aspirin in Gestation and Reproduction: A Multi-center, Controlled, Double-blind Randomized Trial.[NCT00467363] | 1,228 participants (Actual) | Interventional | 2007-06-30 | Completed | |||
| Investigation Of The Utility Of Home Blood Pressure Measurements Towards Improving The Management Of Hypertension In Patients In Stage 3 And 4 Chronic Kidney Disease[NCT03588520] | 70 participants (Anticipated) | Interventional | 2018-06-02 | Recruiting | |||
| Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)[NCT02409680] | 11,976 participants (Actual) | Interventional | 2016-03-23 | Completed | |||
| Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)[NCT03152058] | Phase 2 | 55 participants (Anticipated) | Interventional | 2017-05-17 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Partial or complete abruption (ie, premature separation of the placenta) (NCT00467363)
Timeframe: until delivery
| Intervention | participants (Number) |
|---|---|
| Aspirin | 7 |
| Placebo | 5 |
(NCT00467363)
Timeframe: 8-weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 374 |
| Placebo | 346 |
Implantation failures (NCT00467363)
Timeframe: 8 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 28 |
| Placebo | 27 |
(NCT00467363)
Timeframe: within 6 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 3 |
| Placebo | 3 |
(NCT00467363)
Timeframe: until 40 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 4 |
| Placebo | 6 |
(NCT00467363)
Timeframe: within 8-weeks of gestation
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 394 |
| Placebo | 363 |
Live birth was obtained prospectively by maternal report and abstraction from medical records by trained staff . (NCT00467363)
Timeframe: after delivery
| Intervention | livebirths (Number) |
|---|---|
| Aspirin | 309 |
| Placebo | 286 |
(NCT00467363)
Timeframe: 8 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 0 |
| Placebo | 0 |
(NCT00467363)
Timeframe: until delivery
| Intervention | participants (Number) |
|---|---|
| Aspirin | 32 |
| Placebo | 30 |
Includes preembryonic and embryonic losses (exclusive of implantation failures) (NCT00467363)
Timeframe: less than 10-weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 56 |
| Placebo | 53 |
(NCT00467363)
Timeframe: until delivery
| Intervention | infants (Number) |
|---|---|
| Aspirin | 22 |
| Placebo | 31 |
birthweight (NCT00467363)
Timeframe: until delivery
| Intervention | grams (Mean) |
|---|---|
| Aspirin | 3327 |
| Placebo | 3315 |
(NCT00467363)
Timeframe: 40 weeks
| Intervention | participants (Number) |
|---|---|
| Aspirin | 2 |
| Placebo | 2 |
- Early preterm delivery (<34 weeks) (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 189 |
| Placebo Arm | 230 |
- Birth weight <2500g (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 1078 |
| Placebo Arm | 1153 |
- Birth weight <1500g (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 78 |
| Placebo Arm | 101 |
- Incidence of Fetal Loss (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 303 |
| Placebo Arm | 353 |
- Incidence of Spontaneous Abortion (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 134 |
| Placebo Arm | 152 |
- Incidence of All stillbirth (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 141 |
| Placebo Arm | 166 |
- Incidence of Medical Termination of Pregnancy (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 42 |
| Placebo Arm | 30 |
- Hypertensive disorders of pregnancy is defined by the characterization of evidence of a hypertensive disorder, including either preeclampsia or eclampsia occurring during the pregnancy. (NCT02409680)
Timeframe: Evidence of hypertensive disorder during the pregnancy (prior to delivery/birth)
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 352 |
| Placebo Arm | 325 |
- Incidence of Perinatal Mortality (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 264 |
| Placebo Arm | 309 |
The primary outcome of this study is incidence of preterm birth, which will be defined as delivery at or after 20 0/7 weeks and prior to 37 0/7 weeks. This will be determined based on actual date of delivery in comparison to the projected estimated due date (EDD), independent of whether or not the preterm delivery is indicated or spontaneous. (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 668 |
| Placebo Arm | 754 |
- Small for gestational age (SGA) as defined by the INTERGROWTH-21st standard (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 1506 |
| Placebo Arm | 1564 |
- Vaginal bleeding (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 214 |
| Placebo Arm | 246 |
- Antepartum hemorrhage (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 26 |
| Placebo Arm | 25 |
- Postpartum hemorrhage (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 54 |
| Placebo Arm | 43 |
- Incidence of Maternal Mortality (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 9 |
| Placebo Arm | 12 |
- Incidence of Late Abortion (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 23 |
| Placebo Arm | 30 |
Hemoglobin < 7.0 gm/dl at 26-30 weeks gestation or a drop of 3.5+ gm/dl from screening to 26-30 weeks gestation (NCT02409680)
Timeframe: At enrollment, 4 weeks post enrollment, and 26-30 weeks GA.
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 290 |
| Placebo Arm | 333 |
Early preterm delivery (<34 weeks) and hypertensive disorders (i.e.: preeclampsia) (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 8 |
| Placebo Arm | 21 |
36 reviews available for aspirin and Abortion, Spontaneous
| Article | Year |
|---|---|
Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis.
Topics: Abortion, Spontaneous; Adalimumab; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxych | 2022 |
Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Birth Rate; | 2023 |
Interventions to prevent miscarriage.
Topics: Abortion, Habitual; Abortion, Spontaneous; Aspirin; Female; Heparin; Humans; Hypothyroidism; Pregnan | 2023 |
Comparison of therapeutic interventions for recurrent pregnancy loss in association with antiphospholipid syndrome: A systematic review and network meta-analysis.
Topics: Abortion, Spontaneous; Animals; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-W | 2020 |
Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations.
Topics: Abortion, Habitual; Abortion, Spontaneous; Anticoagulants; Aspirin; Combined Modality Therapy; Femal | 2021 |
Aspirin for Endometrial Preparation in Patients Undergoing IVF: A Systematic Review and Meta-analysis.
Topics: Abortion, Spontaneous; Aspirin; Female; Fertilization in Vitro; Humans; Live Birth; Ovulation Induct | 2021 |
Pregnancy and Lupus Nephritis.
Topics: Abortion, Spontaneous; Anticoagulants; Antihypertensive Agents; Antiphospholipid Syndrome; Aspirin; | 2015 |
Pregnancy in women with systemic lupus erythematosus (SLE).
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspi | 2016 |
Anti-phospholipid antibodies and other immunological causes of recurrent foetal loss--a review of literature of various therapeutic protocols.
Topics: Abortion, Spontaneous; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Aspirin; Clinical Tri | 2009 |
Lupus and pregnancy: integrating clues from the bench and bedside.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Azathioprine; Counseli | 2011 |
Randomized controlled trials: part 17 of a series on evaluation of scientific publications.
Topics: Abortion, Spontaneous; Aspirin; Biomarkers; Drug Approval; Drug Therapy, Combination; Female; Fibrin | 2011 |
Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature.
Topics: Abortion, Spontaneous; Adult; Aspirin; Embryo Implantation; Female; Fertility Agents; Fertilization | 2012 |
[Anticoagulation and antiaggregation during pregnancy].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abruptio Placentae; Administration, Oral; Adult; | 2003 |
Antiphospholipid syndrome in obstetrics.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Annexin A5; Antibodies, Anticardiolipin; Anticoagu | 2003 |
Antibody-mediated thrombosis and pregnancy loss.
Topics: Abortion, Spontaneous; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination | 2003 |
[Factor V Leiden mutation and pregnancy complications].
Topics: Abortion, Spontaneous; Activated Protein C Resistance; Adult; Anticoagulants; Aspirin; Factor V; Fem | 2003 |
Pregnancy in essential thrombocythaemia: experience with 40 pregnancies.
Topics: Abortion, Spontaneous; Anticoagulants; Aspirin; Eclampsia; Female; Fetal Death; Finland; Humans; Pla | 2004 |
Inherited and acquired thrombophilia: pregnancy outcome and treatment.
Topics: Abortion, Spontaneous; Abruptio Placentae; Anticoagulants; Aspirin; Female; Fetal Growth Retardation | 2006 |
Anticoagulation for pregnant patients with mechanical heart valves.
Topics: Abortion, Spontaneous; Anticoagulants; Aspirin; Drug Administration Schedule; Female; Fetal Diseases | 2007 |
[The antiphospholipid syndrome, an update].
Topics: Abortion, Spontaneous; Acenocoumarol; Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphosph | 2007 |
[Pregnancy in essential thrombocythemia. Manifestation time and risk for mother and child].
Topics: Abortion, Spontaneous; Adult; Aspirin; Female; Fetal Death; Growth Disorders; Humans; Infant, Newbor | 1995 |
[Pathogenesis on infertility; its immunological aspects].
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Aspirin; Autoimmune Diseases; Cytokines; Female | 1993 |
Essential thrombocythemia and pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Aspirin; Busulfan; Combined Modality Therapy; Di | 1996 |
Treatment of the antiphospholipid syndrome in pregnancy.
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Anticoagula | 1998 |
[Current obstetrical management of antiphospholipid antibody syndrome: review of the literature apropos of 20 cases].
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Anticoagulants; Antiphospholipid Syndrome; Aspirin; | 1998 |
Fertility, pregnancy and the management of myeloproliferative disorders.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Alkylating Agents; Animals; Aspirin; Bone Marrow | 1998 |
[Antiphospholipid antibody syndrome in adverse pregnancy].
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; A | 2000 |
[Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome].
Topics: Abortion, Habitual; Abortion, Spontaneous; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Femal | 2000 |
Treatment of the antiphospholipid antibody syndrome: progress in the last five years?
Topics: Abortion, Spontaneous; Antiphospholipid Syndrome; Aspirin; B-Lymphocytes; Hematopoietic Stem Cell Tr | 2000 |
A single institutional experience with 43 pregnancies in essential thrombocythemia.
Topics: Abortion, Induced; Abortion, Spontaneous; Abruptio Placentae; Adult; Anticoagulants; Aspirin; Busulf | 2001 |
Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature.
Topics: Abortion, Spontaneous; Aspirin; Blood Component Removal; Female; Fetal Death; Gestational Age; Human | 2002 |
Treatment of the antiphospholipid syndrome.
Topics: Abortion, Spontaneous; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Humans; Nerv | 2002 |
Autoimmune factors in assisted reproduction.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adrenal Cortex Hormones; Antibodies, Anticardiolipin; Ant | 2002 |
Inhibition of uterine motility: the possible role of the prostaglandins and aspirin-like drugs.
Topics: Abortion, Induced; Abortion, Spontaneous; Animals; Aspirin; Depression, Chemical; Dogs; Endotoxins; | 1975 |
[Role of antiphospholipid antibodies in fetal loss].
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Antibodies, Anticardiolipin; Antibodies, Antiphospho | 1992 |
[Present position of the toxicology of drugs].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Amantadine; Aminopterin; Animals; Animals, Newbo | 1970 |
18 trials available for aspirin and Abortion, Spontaneous
| Article | Year |
|---|---|
Use of Machine Learning to Estimate the Per-Protocol Effect of Low-Dose Aspirin on Pregnancy Outcomes: A Secondary Analysis of a Randomized Clinical Trial.
Topics: Abortion, Spontaneous; Adult; Aspirin; Double-Blind Method; Female; Humans; Machine Learning; Male; | 2022 |
Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial.
Topics: Abortion, Spontaneous; Adolescent; Adult; Aspirin; Asymptomatic Diseases; Cohort Studies; Exercise; | 2020 |
The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth : Per Protocol Analysis of a Randomized Trial.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chorionic Gonadotrop | 2021 |
Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Rate; C-Reacti | 2017 |
Preconception Blood Pressure Levels and Reproductive Outcomes in a Prospective Cohort of Women Attempting Pregnancy.
Topics: Abortion, Spontaneous; Adult; Aspirin; Blood Pressure; Blood Pressure Determination; Cohort Studies; | 2018 |
Does low-dose aspirin improve pregnancy rate in women undergoing frozen-thawed embryo transfer cycle? A pilot double-blind, randomized placebo-controlled trial.
Topics: Abortion, Spontaneous; Adult; Aspirin; Cryopreservation; Double-Blind Method; Embryo Implantation; E | 2019 |
Metabolic Syndrome and the Effectiveness of Low-dose Aspirin on Reproductive Outcomes.
Topics: Abortion, Spontaneous; Adult; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Drug A | 2019 |
Sex ratio following preconception low-dose aspirin in women with prior pregnancy loss.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; | 2015 |
Antimüllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction trial.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anti-Mullerian Hormone; Aspirin; Biomarkers; Cohort Studie | 2016 |
Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss.
Topics: Abortion, Spontaneous; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Pregnancy; P | 2016 |
Association of Nausea and Vomiting During Pregnancy With Pregnancy Loss: A Secondary Analysis of a Randomized Clinical Trial.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarke | 2016 |
Low-dose aspirin and omega-3 fatty acids improve uterine artery blood flow velocity in women with recurrent miscarriage due to impaired uterine perfusion.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Arteries; Aspirin; Blood Flow Velocity; Cyclooxyge | 2009 |
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Confidence | 2002 |
Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Topics: Abortion, Induced; Abortion, Spontaneous; Aspirin; Blood Pressure; Female; Humans; Logistic Models; | 1995 |
[Acetylsalicylic acid and kurantil in the prevention of pregnancy complications in glomerulonephritis and hypertension].
Topics: Abortion, Spontaneous; Analysis of Variance; Aspirin; Chronic Disease; Dipyridamole; Drug Therapy, C | 1993 |
The presence of anti-beta 2-glycoprotein I and anti-prothrombin antibodies and their correlations with venous and arterial thrombosis.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Aspirin; Dose-Response Relationship, Drug; Drug | 1996 |
Prevention of early pregnancy loss in autoantibody seropositive women.
Topics: Abortion, Spontaneous; Aspirin; Autoantibodies; Embryo Transfer; Female; Fertilization in Vitro; Hum | 1998 |
Recurrent miscarriage--an aspirin a day?
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Aspirin; Birth Rate; | 2000 |
60 other studies available for aspirin and Abortion, Spontaneous
| Article | Year |
|---|---|
Low-dose aspirin protects unexplained recurrent spontaneous abortion
Topics: Abortion, Spontaneous; Animals; Aspirin; Down-Regulation; Female; HMGB1 Protein; Humans; Infant; Inf | 2022 |
Low-dose aspirin protects unexplained recurrent spontaneous abortion
Topics: Abortion, Spontaneous; Animals; Aspirin; Down-Regulation; Female; HMGB1 Protein; Humans; Infant; Inf | 2022 |
Low-dose aspirin protects unexplained recurrent spontaneous abortion
Topics: Abortion, Spontaneous; Animals; Aspirin; Down-Regulation; Female; HMGB1 Protein; Humans; Infant; Inf | 2022 |
Low-dose aspirin protects unexplained recurrent spontaneous abortion
Topics: Abortion, Spontaneous; Animals; Aspirin; Down-Regulation; Female; HMGB1 Protein; Humans; Infant; Inf | 2022 |
Low Molecular Weight Heparin-Aspirin-Prednisolone Combination Does Not Increase the Live Birth Rate in Recurrent Implantation Failure: A Retrospective Cohort Study.
Topics: Abortion, Spontaneous; Aspirin; Birth Rate; Female; Fertilization in Vitro; Heparin, Low-Molecular-W | 2023 |
The Relationship of Preconception and Early Pregnancy Isoprostanes with Fecundability and Pregnancy Loss.
Topics: Abortion, Spontaneous; Aspirin; Female; Fertility; Humans; Isoprostanes; Pregnancy | 2023 |
Gastrointestinal and uterine smooth muscles relaxant and anti-inflammatory effects of corchorus olitorius leaf extract in laboratory animal models.
Topics: Abortion, Spontaneous; Animals; Anti-Inflammatory Agents; Antidiarrheals; Aspirin; Corchorus; Diarrh | 2020 |
Precision medicine and the antiphospholipid syndrome: what is the future?
Topics: Abortion, Spontaneous; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; An | 2020 |
Destruction in maternal-fetal interface of URSA patients via the increase of the HMGB1-RAGE/TLR2/TLR4-NF-κB signaling pathway.
Topics: Abortion, Habitual; Abortion, Spontaneous; Antigens, Neoplasm; Aspirin; Female; Fetus; Gene Expressi | 2020 |
Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety.
Topics: Abortion, Spontaneous; Adult; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Interferon-alp | 2021 |
"Part of the Ritual": Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome.
Topics: Abortion, Spontaneous; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Attitude of Health Person | 2021 |
Summary for Patients: The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chorionic Gonadotrop | 2021 |
Recurrent Massive Perivillous Fibrin Deposition and Chronic Intervillositis Treated With Heparin and Intravenous Immunoglobulin: A Case Report.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Anticoagulants; Aspirin; Chorionic Villi; Daltepar | 2017 |
[Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome].
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; | 2018 |
An Irish National Diabetes in Pregnancy Audit: aiming for best outcomes for women with diabetes.
Topics: Abortion, Spontaneous; Adult; Aspirin; Cesarean Section; Clinical Audit; Delivery of Health Care; De | 2020 |
Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Case | 2013 |
A retrospective study on IVF/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antinuclear; Aspirin; Female; Fertilization in Vitro; Huma | 2013 |
[Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study].
Topics: Abortion, Spontaneous; Antiphospholipid Syndrome; Aspirin; Female; Fetal Growth Retardation; Heparin | 2014 |
Successful pregnancy outcome with comprehensive treatment after 13 consecutive pregnancy losses.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Aspirin; Female; Heparin, Low-Molecular-Weight; Hu | 2014 |
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomized trial.
Topics: Abortion, Spontaneous; Aspirin; Birth Rate; Female; Humans; Ireland; Live Birth; Pre-Eclampsia; Preg | 2015 |
Does consumption of platelet-derived microparticles in the fibrin clot explain the decrease in their percentage during pregnancy?
Topics: Abortion, Spontaneous; Anticoagulants; Aspirin; Blood Platelets; Cell-Derived Microparticles; Female | 2016 |
Effect of Low-Dose Aspirin on Midluteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Flow Velocity; | 2016 |
Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile.
Topics: Abortion, Spontaneous; Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospho | 2017 |
Pregnancy in β-thalassemia intermedia at two tertiary care centers in Lebanon and Italy: A follow-up report on fetal and maternal outcomes.
Topics: Abortion, Habitual; Abortion, Spontaneous; Aspirin; beta-Thalassemia; Birth Weight; Cesarean Section | 2017 |
Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies.
Topics: Abortion, Spontaneous; Adolescent; Adult; Aspirin; Female; Humans; Janus Kinase 2; Leukocyte Count; | 2009 |
Hughes syndrome (the antiphospholipid syndrome): a disease of our time.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Arterial Occlusive D | 2011 |
A practical approach to the prevention of miscarriage: part 5--antiphospholipid syndrome as a cause of spontaneous abortion.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspi | 2011 |
First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Anticoagulants | 2011 |
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.
Topics: Abortion, Spontaneous; Adult; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Biomarkers; C | 2011 |
Bloody mess.
Topics: Abortion, Spontaneous; Antibodies, Anticardiolipin; Aspirin; Female; Fibrinolytic Agents; Heparin; H | 2011 |
Bloody tests.
Topics: Abortion, Spontaneous; Antibodies, Anticardiolipin; Aspirin; Female; Fibrinolytic Agents; Hematologi | 2011 |
Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation.
Topics: Abortion, Spontaneous; Adult; Aspirin; Case-Control Studies; Drug Therapy, Combination; Factor V; Fe | 2012 |
Protein A immunoadsorption in a pregnant woman with habitual abortion.
Topics: Abortion, Habitual; Abortion, Spontaneous; Activated Protein C Resistance; Adult; Anticoagulants; An | 2002 |
Longitudinal analysis of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in antiphospholipid syndrome and in healthy pregnancy.
Topics: Abortion, Spontaneous; Abruptio Placentae; Adult; Antiphospholipid Syndrome; Aspirin; Female; Fetal | 2003 |
Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study.
Topics: Abortion, Spontaneous; Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studi | 2003 |
[Which abortion prevention should be chosen in the case of antiphospholipid syndrome?].
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Adult; Anticoagulants; Antiphospholipid Syndrome; As | 2004 |
Are low doses of enoxaparin with aspirin sufficient to guarantee good gestational outcome in women with heterozygote factor V Leiden mutation?
Topics: Abortion, Spontaneous; Adult; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Factor | 2007 |
Aspirin use and miscarriage risk.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies | 2006 |
Periodic plateletpheresis during pregnancy in a high-risk patient with essential thrombocythemia.
Topics: Abortion, Spontaneous; Adult; Anticoagulants; Aspirin; Blood Flow Velocity; Cesarean Section; Female | 2006 |
[Low dose of aspirin during pregnancy].
Topics: Abnormalities, Drug-Induced; Abortion, Habitual; Abortion, Spontaneous; Adult; Animals; Anti-Inflamm | 2007 |
Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization.
Topics: Abortion, Spontaneous; Aspirin; Dose-Response Relationship, Drug; Embryo Implantation; Evidence-Base | 2008 |
Prescribing of NSAIDs and ASA during pregnancy; do we need to be more careful?
Topics: Abortion, Spontaneous; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Congenit | 2008 |
Antiphospholipid antibodies and pregnancy wastage.
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; | 1994 |
Effect of prostaglandin synthesis inhibitors on spontaneous and endotoxin-induced abortion in mice.
Topics: Abortion, Spontaneous; Animals; Aspirin; Cyclooxygenase Inhibitors; Dinoprostone; Female; Indomethac | 1993 |
Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug | 1993 |
Antiphospholipid antibodies, low-dose aspirin and pregnancy losses.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Aspirin; Female; Humans; Pregnancy | 1996 |
Efficacy of low dose prednisone plus aspirin in preventing spontaneous abortions and/or fetal deaths due to antiphospholipid antibodies: results of a pilot study.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Aspirin; Drug Administration Schedule; D | 1996 |
Pregnancy outcome. Influence of antiphospholipid antibody titer, prior pregnancy losses and treatment.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Fema | 1997 |
Autoantibodies and pregnancy loss.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Aspirin; Autoantibodies; Blood Coagulation; Fem | 1997 |
Obstetric outcome in antiphospholipid syndrome.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anticardiolipin; | 1997 |
Titration of antiplatelet treatment in pregnant women at risk of preeclampsia.
Topics: Abortion, Spontaneous; Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; | 1998 |
Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies.
Topics: Abortion, Spontaneous; Adult; Aspirin; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Pl | 2000 |
Low-dose aspirin is effective for treatment of recurrent miscarriage in patients with decreased coagulation factor XII.
Topics: Abortion, Spontaneous; Adult; Aspirin; Dose-Response Relationship, Drug; Factor XII Deficiency; Fema | 2001 |
Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis.
Topics: Abortion, Spontaneous; Adolescent; Adult; Antiphospholipid Syndrome; Aspirin; Female; Humans; Multiv | 2001 |
Pregnancy outcome after suicide attempt by drug use: a Danish population-based study.
Topics: Abortion, Spontaneous; Acetaminophen; Adolescent; Adult; Aspirin; Child; Child, Preschool; Denmark; | 2002 |
Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Aspirin; Controlled Clinical Trials as T | 2002 |
Embryotoxicity of solanine and aspirin in mice.
Topics: Abortion, Spontaneous; Animals; Aspirin; Drug Synergism; Female; Fetal Resorption; Fetus; Mice; Preg | 1976 |
Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin.
Topics: Abortion, Spontaneous; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Enzym | 1992 |
Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment.
Topics: Abortion, Spontaneous; Antibodies; Aspirin; Female; Fetal Death; Humans; Lupus Erythematosus, System | 1989 |
Obstetric complications associated with the lupus anticoagulant.
Topics: Abortion, Spontaneous; Aspirin; Blood Coagulation Factors; Blood Coagulation Tests; Female; Fetal De | 1985 |
Prostaglandins and aspirin.
Topics: Abortion, Spontaneous; Anti-Inflammatory Agents; Aspirin; Embryo Implantation; Female; Humans; Male; | 1972 |
[Prostaglandins].
Topics: Abortion, Spontaneous; Animals; Aspirin; Drug Interactions; Female; Humans; Male; Pregnancy; Prostag | 1973 |
[Therapy in decompression sickness and air embolism].
Topics: Abortion, Spontaneous; Adult; Air; Animals; Arteries; Aspirin; Blood Platelets; Capillaries; Child; | 1971 |